AI Article Synopsis
- Gastric cancer (GC) shows significant geographical and socioeconomic variation, impacting how it is studied and treated.
- Sentinel lymph node (SLN) mapping is a method to track the spread of cancer through lymphatic systems, but its complexity in gastric cases presents challenges and requires careful application, especially for smaller tumors (T1 and under 4 cm).
- Despite some limitations, SLN mapping combined with blue dye and radioactive colloid offers a new approach to customize surgical procedures like lymphadenectomy in GC treatment.
Article Abstract
Gastric cancer (GC) remains one of the most important malignant diseases with significant geographical, ethnic, and socioeconomic differences in distribution. Sentinel lymph node (SLN) mapping is an accepted way to assess lymphatic spread in several solid tumors; however, the complexity of gastric lymphatic drainage may discourage use of this procedure, and the estimated accuracy rate is, in general, reasonably good. This study aimed at reviewing the current status of SLN mapping and navigation surgery in GC. SLN mapping should be limited to tumors clinically T1 and less than 4 cm in diameter. Combination SLN mapping with radioactive colloid and blue dye is used as the standard. Despite its notable limitations, SLN mapping and SLN navigation surgery present a novelty individualizing the extent of lymphadenectomy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963302 | PMC |
| http://dx.doi.org/10.47717/turkjsurg.2020.4932 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!